课题基金 / 基金详情

BLOCKAGE OF TOXIN-CELL INTERACTIONS BY OLIGOSACCHARIDES

BLOCKAGE OF TOXIN-CELL INTERACTIONS BY OLIGOSACCHARIDES
低聚糖阻断毒素与细胞的相互作用
批准号:
3136052
负责人:
Cara-Lynne Schengrund
金额:
$16.01万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-07-01 至 1994-06-30

项目摘要

项目成果

Cara-Lynne Schengrund的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The overall goal of this proposal is to understand how clostridial neurotoxins interact with their target cells and to use this knowledge to develop effective inhibitors of the toxin-cell interaction. Three botulinum toxins (A,B and E) will be studied to determine whether observations made with one toxin (botulinum toxin A) might have general applicability. If the botulinum toxins behave similarly, comparisons will be made to tetanus toxin to determine what similarities exist between the two classes of neurotoxins. Specifically, studies of the binding of botulinum toxins B and E to G1b gangliosides and derivatives thereof will be carried out. Results will be compared to those obtained for botulinum toxin A and tetanus toxin. Accumulating evidence suggests that gangliosides may not be the only cell surface receptor for these neurotoxins. In recent studies, we have found that botulinum toxin A, its heavy chain and the carboxy terminal half of the heavy chain bind to synaptosomal proteins. Tetanus toxin also adhered to synaptosomal proteins but it had to be preincubated with GT1b in order to bind to protein. The protein adhered to by both neurotoxins has an apparent molecular weight of approximately 77 kDa and is glycosylated. Experiments designed to purify and characterize the approximately kDa protein will be continued, and the site(s) adhered to by the toxin will be identified as will the portion of the neurotoxin responsible for the binding, and in in vitro experiments designed to identify the functional aspects of specific interactions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Can mannosylated dendrimers inhibit HIV-1 infection of DC-SIGN expressing cells
Can mannosylated dendrimers inhibit HIV-1 infection of DC-SIGN expressing cells
ROLES(S) OF GLYCOSPHINGOLIPIDS IN NEURAL AIDS
ROLES(S) OF GLYCOSPHINGOLIPIDS IN NEURAL AIDS
海外基金